IBEX Ltd (IBEX) Balance Sheet

As of 2026-06-30 (10-K), IBEX Ltd (IBEX) reported total assets of $309.1M, total liabilities of $138.9M and shareholders' equity of $170.2M, according to EquiReason's reading of its SEC filings. Cash and equivalents: $32.6M. Long-term debt: $777000.

Source: SEC EDGAR filings · figures as of 2026-06-30 · read by EquiReason

IBEXIBEX LtdFollow IBEX — free

Information Technology Services · Technology

—

Price chart with a free account

Market cap: 627.1M
P/E TTM: 15.1
Dividend yield: —
52-week: —
Next earnings: 5 Nov, in 12 days

Line	FY2019 Jun 19	FY2020 Jun 20	FY2021 Jun 21	FY2022 Jun 22	FY2023 Jun 23	FY2024 Jun 24	FY2025 Jun 25	FY2026 Jun 26	Latest Jun 26
Cash and equivalents	—	21.9	57.8	48.8	57.4	62.7	15.4	32.6	32.6
Receivables	—	—	—	75.4	86.4	98.4	117.1	125.3	125.3
Current assets	81.8	86.0	141.4	142.4	158.6	180.0	145.6	179.6	179.6
Total assets	188.3	195.2	274.3	294.2	293.3	293.9	273.2	309.1	309.1
Current liabilities	111.4	105.7	105.7	97.8	73.3	71.0	79.9	85.5	85.5
Long-term debt	7.2	3.8	1.8	0.7	0.6	0.9	0.8	0.8	0.8
Short-term debt	41.8	27.5	26.7	15.1	0.4	0.7	0.8	0.9	0.9
Total liabilities	179.7	179.1	193.6	180.7	143.4	128.1	138.9	138.9	138.9
Shareholders' equity	8.6	18.7	94.7	113.5	150.0	165.8	134.3	170.2	170.2

USD millions · SEC XBRL

IBEX Ltd — questions

How much cash does IBEX Ltd have?: $32.6M in cash and cash equivalents as of 2026-06-30.
How much debt does IBEX Ltd have?: $777000 of long-term debt and $882000 due within a year as of 2026-06-30.
What are IBEX Ltd's total assets?: $309.1M as of 2026-06-30.
What is IBEX Ltd's shareholders' equity?: $170.2M as of 2026-06-30.

Every figure on this page comes from IBEX Ltd's own SEC filings — see them on SEC EDGAR. Price data is licensed and shown only inside the product.

How these figures are read: methodology · EquiReason.

Important information. Figures on this page are taken from filings submitted to the U.S. Securities and Exchange Commission (SEC) and processed automatically by EquiReason. They may contain errors, omissions or delays, and EquiReason makes no representation or warranty as to their accuracy, completeness or timeliness. Always verify figures against the original filing on SEC EDGAR before relying on them.

This page is provided for general information and educational purposes only. It does not constitute investment, financial, legal or tax advice, and it is not a recommendation or an offer to buy, sell or hold any security. It does not take into account your objectives, financial situation or needs. Past performance does not guarantee future results; any reliance on this information is at your own risk. See our Disclaimer and Risk Disclosure.